Cargando…
Evaluation of neural damage in Duchenne muscular dystrophy patients
The presence of non-progressive cognitive impairment is recognized as a common feature in a substantial proportion of patients with Duchenne muscular dystrophy (DMD). Concurrently, the amyloid beta peptide (Aβ(42)) protein has been associated with changes in memory and cognitive functions. Also, it...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Pacini Editore SpA
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021626/ https://www.ncbi.nlm.nih.gov/pubmed/24843230 |